市中肺炎の臨床合併症を改善するための抗血栓療法 (ATTACC-CAP)
This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeutic-dose heparin vs. usual care pharmacological thromboprophylaxis on outcomes in patients admitted to hospital with community acquired pneumonia (CAP).
調査の概要
詳細な説明
The global incidence of hospitalization due to CAP is high and associated with substantive morbidity and mortality. Thrombotic complications - including venous, arterial, and possibly microvascular - occur commonly in hospitalized patients across many etiologies of CAP. Poor outcomes may be mediated by both inflammatory and thrombotic processes leading to respiratory, cardiac, and other end organ dysfunction. There are currently no established therapies that modify the potentially maladaptive immunothrombosis pathway in CAP.
Therapeutic-dose anticoagulation with heparin reduces disease progression and mortality in non-critically ill patients hospitalized with COVID-19 with an acceptable safety profile. COVID-19 shares pathogenic features, including activation of the inflammatory and coagulation cascades, with other pneumonias. Whether therapeutic-dose heparin confers similar clinical benefits in non-COVID-19 CAP is unknown.
研究の種類
入学 (推定)
段階
- フェーズ 3
連絡先と場所
研究連絡先
- 名前:Chantale Pineau
- 電話番号:2042353223
- メール:attacc.cap@umanitoba.ca
研究場所
-
-
Illinois
-
Chicago、Illinois、アメリカ、60637
- 募集
- University of Chicago
-
コンタクト:
- Jonathan Paul, MD
-
-
Louisiana
-
Jefferson、Louisiana、アメリカ、70121
- 募集
- Ochsner Clinic
-
コンタクト:
- Derek Vondehaar, MD
-
-
Maine
-
Portland、Maine、アメリカ、04102
- 募集
- Maine Medical Centre
-
コンタクト:
- Daniel Meyer, MD
-
主任研究者:
- Daniel Meyer, MD
-
-
Michigan
-
Dearborn、Michigan、アメリカ、48128
- 完了
- Henry Ford Health System
-
-
New Jersey
-
Camden、New Jersey、アメリカ、08103
- 募集
- Cooper University Health Care
-
コンタクト:
- Adam Green, MD
-
主任研究者:
- Adam Green, MD
-
-
Wisconsin
-
Milwaukee、Wisconsin、アメリカ、53226
- 募集
- Medical College of Wisconsin
-
コンタクト:
- Alisha Sharma, MD
-
主任研究者:
- Alisha Sharma, MD
-
-
-
-
Alberta
-
Calgary、Alberta、カナダ、T2N 2T9
- 募集
- Foothills Medical Centre - Alberta Health Services
-
コンタクト:
- Deepa Suryanarayan, MD
- 電話番号:4039448167
- メール:dsuryana@ucalgary.ca
-
主任研究者:
- Deepa Suryanarayan, MD
-
Grande Prairie、Alberta、カナダ、T8V 4B1
- まだ募集していません
- Grand Prairie Regional Hospital
-
コンタクト:
- Tafi Madzimure, MD
-
主任研究者:
- Tafi Madzimure, MD
-
-
British Columbia
-
Nanaimo、British Columbia、カナダ
- 募集
- Nanaimo Regional General Hospital
-
コンタクト:
- Alistair Teale, MD
-
主任研究者:
- Alistair Teale, MD
-
Penticton、British Columbia、カナダ
- まだ募集していません
- Penticton Regional Hospital
-
コンタクト:
- Teresa Rodriguez, MD
-
Vancouver、British Columbia、カナダ、V5Z 1M9
- 募集
- Vancouver General Hospital
-
主任研究者:
- Ted Steiner, MD
-
コンタクト:
- Ted Steiner, MD
-
-
Manitoba
-
Winnipeg、Manitoba、カナダ
- 募集
- St. Boniface General Hospital
-
コンタクト:
- Vi Dao, MD
-
主任研究者:
- Terry Wuerz, MD
-
主任研究者:
- Vi Dao, MD
-
Winnipeg、Manitoba、カナダ、R3A 1R9
- 募集
- Health Sciences Center Winnipeg
-
コンタクト:
- Brett Houstin, MD
-
Winnipeg、Manitoba、カナダ
- 募集
- Grace General Hospital
-
コンタクト:
- Sylvain Lother, MD
- メール:sylvain.lother@umanitoba.ca
-
主任研究者:
- Sylvain Lother, MD
-
-
Newfoundland and Labrador
-
St. John's、Newfoundland and Labrador、カナダ、A1C 5S7
- 募集
- Memorial University
-
コンタクト:
- Peter Daley, MD
-
主任研究者:
- Peter Daley, MD
-
-
Ontario
-
Greater Sudbury、Ontario、カナダ、P3E 2H3
- 募集
- Health Sciences North Research Institute
-
コンタクト:
- Pandma Puranam, MD
-
主任研究者:
- Pandma Puranam, MD
-
Greater Sudbury、Ontario、カナダ
- 募集
- Health Sciences North ResearchInstitute (HSNRI)
-
コンタクト:
- Pandma Puranam, MD
-
Hamilton、Ontario、カナダ
- 募集
- Hamilton Health Sciences
-
コンタクト:
- Alison Fox-Robichaud, MD
-
主任研究者:
- Alison Fox-Robichaud, MD
-
Hamilton、Ontario、カナダ
- 募集
- Hamilton Health Sciences - Juravinski
-
主任研究者:
- Dominik Mertz, MD
-
主任研究者:
- Bram Rochwerg, MD
-
コンタクト:
- Bram Rochwerg, MD
-
Markham、Ontario、カナダ、L3P 7P3
- 募集
- Markham Stouffville Hospital
-
主任研究者:
- Paul Lee, MD
-
コンタクト:
- Paul Lee, MD
-
主任研究者:
- Janet Nguyen, MD
-
Ottawa、Ontario、カナダ
- 募集
- The Ottawa Hospital
-
コンタクト:
- Lana Castellucci, MD
-
Ottawa、Ontario、カナダ
- 募集
- Hôpital Montfort
-
コンタクト:
- Marc Carrier, MD
-
Saint Catherines、Ontario、カナダ、L2S 0A9
- 募集
- Niagara Health System - St Catharines Site
-
コンタクト:
- Aidan Findlater, MD
- メール:Aidan.Findlater@niagarahealth.on.ca
-
主任研究者:
- Aidan Findlater, MD
-
Toronto、Ontario、カナダ、M4N 3M5
- 募集
- Sunnybrook Health Sciences Centre
-
コンタクト:
- Jonathan Zipursky, MD
-
主任研究者:
- Jonathan Zipursky, MD
-
Toronto、Ontario、カナダ
- まだ募集していません
- St. Michael's Hospital
-
コンタクト:
- Michael Colacci, MD
-
-
Quebec
-
Montreal、Quebec、カナダ
- 募集
- Jewish General Hospital
-
コンタクト:
- Susan Khan, MD
-
コンタクト:
- Vicky Tagalakis, MD
-
Montreal、Quebec、カナダ、H4A3J1
- 募集
- McGill University Health Centre
-
コンタクト:
- Emily Gibson McDonald, MD, MSc
-
Montreal、Quebec、カナダ
- 募集
- Centre Hospitalier de l'université de Montréal (CHUM)
-
コンタクト:
- Emmanuelle Duceppe, MD
-
Québec、Quebec、カナダ
- 募集
- CHU de Quebec-University Laval
-
コンタクト:
- Alexis Turgeon, MD, MSc
-
Québec、Quebec、カナダ
- 募集
- Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ)
-
コンタクト:
- Francois Lallouche, MD
-
Sherbrooke、Quebec、カナダ
- 募集
- Centre Hospitalier Universitaire de Sherbrooke
-
主任研究者:
- Francois Lamontagne, MD
-
コンタクト:
- Francois Lamontagne, MD
-
-
Saskatchewan
-
Regina、Saskatchewan、カナダ、S4P 0W5
- 募集
- Regina General Hospital
-
主任研究者:
- Payam Dehghani, MD
-
コンタクト:
- Payam Dehghani, MD
-
Saskatoon、Saskatchewan、カナダ
- まだ募集していません
- University of Saskatchewan
-
コンタクト:
- Geroffrey Shumailak, MD
-
-
-
-
Espírito Santo
-
Serra、Espírito Santo、ブラジル、29166-828
- 募集
- Hospital Estadual Dr. Jayme Santos Neves
-
コンタクト:
- Marcus Matos, MD
-
主任研究者:
- Marcus Matos, MD
-
Vila Velha、Espírito Santo、ブラジル
- 募集
- Hospital Evangelico de Vila Velha
-
コンタクト:
- Joao Moraes Junior, MD
-
主任研究者:
- Joao Moraes Junior, MD
-
主任研究者:
- Guiherme Fonseca, MD
-
-
Estado de Bahia
-
Itabuna、Estado de Bahia、ブラジル
- 完了
- Santa Casa de Misericordia de Itabuna
-
-
Federal District
-
Brasília、Federal District、ブラジル
- 完了
- Hospital Brasilia
-
Brasília、Federal District、ブラジル
- 完了
- Instituto de Cardiologia e Transplantes do Distrito Federal
-
-
Goiás
-
Goiânia、Goiás、ブラジル
- 募集
- Hospital de Messejana Dr. Carlos Alberto Studart Gomes
-
コンタクト:
- Sandra Nivea dos Reis Saraiva, MD
-
主任研究者:
- Sandra Falcao, MD
-
Goiânia、Goiás、ブラジル
- 募集
- Hospital Ruy Azeredo
-
コンタクト:
- Rafael Bastos, MD
-
主任研究者:
- Rafael Bastos, MD
-
Goiânia、Goiás、ブラジル
- 募集
- Instituto Goiano de Oncologia e Hematologia - INGOH
-
コンタクト:
- Mayler Santos, MD
-
主任研究者:
- Mayler Santos, MD
-
-
Mato Grosso do Sul
-
Campo Grande、Mato Grosso do Sul、ブラジル
- 募集
- Hospital São Julião
-
コンタクト:
- Maurício Pompílio Pompílio, MD
-
Campo Grande、Mato Grosso do Sul、ブラジル
- 募集
- Santa Casa de Campo Grande
-
コンタクト:
- Eduardo Calvoso, MD
-
-
Minas Gerais
-
Belo Horizonte、Minas Gerais、ブラジル
- 完了
- Hospital Felicio Rocho
-
Belo Horizonte、Minas Gerais、ブラジル
- 完了
- NUPEC-Orizonti
-
Belo Horizonte、Minas Gerais、ブラジル
- 募集
- Santa Casa de Misericórdia de Belo Horizonte
-
コンタクト:
- Claudio Dornas, MD
-
Uberaba、Minas Gerais、ブラジル
- 募集
- Hospital das Clínicas da Universidade Federal do Triângulo Mineiro
-
-
Paraná
-
Campo Largo、Paraná、ブラジル、83606-177
- 募集
- Hospital do Rocio
-
コンタクト:
- CESAR DUSILEK, MD
-
Curitiba、Paraná、ブラジル
- 募集
- Hospital Santa Cruz
-
コンタクト:
- Marcelo Carneiro, MD
-
主任研究者:
- Marcelo Carneiro, MD
-
Curitiba、Paraná、ブラジル
- 完了
- PUCPR
-
-
Rio Grande do Sul
-
Lajeado、Rio Grande do Sul、ブラジル
- 募集
- Hospital Bruno Born
-
コンタクト:
- Lucas Mallmann, MD
-
主任研究者:
- Lucas Mallmann, MD
-
Passo Fundo、Rio Grande do Sul、ブラジル
- 募集
- Hospital Sao Vicente de Paulo
-
コンタクト:
- Alexandre Tognon, MD
-
主任研究者:
- Alexandre Tognon
-
Porto Alegre、Rio Grande do Sul、ブラジル
- 募集
- Hospital de Clínicas de Porto Alegre
-
コンタクト:
- Paulo Dalcin, MD
-
主任研究者:
- Paulo Dalcin, MD
-
Santa Maria、Rio Grande do Sul、ブラジル
- 完了
- Hospital Universitario de Santa Maria
-
-
Rio de Janeiro
-
Rio de Janeiro、Rio de Janeiro、ブラジル
- 募集
- Hospital Clementino Fraga Filho - UFRJ
-
コンタクト:
- Fernanda Mello
-
-
Santa Catarina
-
Criciúma、Santa Catarina、ブラジル
- 募集
- Hospital Sao Jose
-
コンタクト:
- Felipe Pizzol, MD
-
主任研究者:
- Felipe Pizzol, MD
-
-
South Carolina
-
São José、South Carolina、ブラジル
- 完了
- Hospital Regional Homero Miranda Gomes
-
-
São Paulo
-
Botucatu、São Paulo、ブラジル
- 募集
- UPECLIN - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu
-
コンタクト:
- Suzana Erico Tanni, MD
-
主任研究者:
- Suzana Erico Tanni, MD
-
Bragança Paulista、São Paulo、ブラジル
- 募集
- Hospital Universitario Sao Francisco na Providencia na Deus
-
コンタクト:
- Gustavo Mamprin, MD
-
主任研究者:
- Gustavo Mamprin, MD
-
Campinas、São Paulo、ブラジル
- 募集
- IPECC
-
コンタクト:
- Jose Francisco Kerr Saraiva, MD
-
主任研究者:
- Jose Francisco Kerr Saraiva, MD
-
Campinas、São Paulo、ブラジル、13083-190
- 募集
- Fundação Centro Médico de Campinas
-
コンタクト:
- Otavio Coelho, MD
-
主任研究者:
- Otavio Coelho, MD
-
Osasco、São Paulo、ブラジル
- 募集
- CiTen - Centro Hospital Municipal Antonio Giglio
-
コンタクト:
- Enrico Fortunato, MD
-
主任研究者:
- Enrico Fortunato, MD
-
Presidente Prudente、São Paulo、ブラジル
- 募集
- Hospital Regional de Presidente Prudente
-
コンタクト:
- Luis Felipe Pires, MD
-
主任研究者:
- Luis Felipe Pires, MD
-
Ribeirão Preto、São Paulo、ブラジル
- まだ募集していません
- Hospital Estadual de Serrana
-
コンタクト:
- Marcos Borges, MD
-
主任研究者:
- Marcos Borges, MD
-
São Paulo、São Paulo、ブラジル、05403-010
- 募集
- HCFMUSP
-
コンタクト:
- Ludhmila Hajjar, MD
-
主任研究者:
- Ludhmila Hajjar, MD
-
São Paulo、São Paulo、ブラジル、02189-010
- 募集
- Hospital Nipo-Brasileiro
-
コンタクト:
- Jose Victor Krasner Schubsky, MD
-
São Paulo、São Paulo、ブラジル
- 完了
- Santa Casa de Misericordia de Sao Paulo
-
-
-
-
Mexico City
-
Mexico City、Mexico City、メキシコ
- 募集
- Hospital General Regional 1. Carlos MacGregor Sánchez Navarro
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
-
Patients ≥18 years of age
-
Admitted to hospital for a suspected or confirmed diagnosis of CAP defined by:
- Radiographic evidence of new or worsening infiltrate
- One or more of the following signs and/or symptoms of lower respiratory tract infection
i. New or increased cough or sputum production ii. Fever of > 37.8C or temperature < 36C iii. WBC > 11 x 109/L or < 4 x 109/L c. The primary diagnosis is believed to be CAP as per the attending physician
-
Requires supplemental oxygen to treat hypoxemia (or requires an increased level of supplemental oxygen if on chronic oxygen therapy)
-
Hospital admission anticipated to last ≥72 hours from randomization
Exclusion Criteria:
-
Suspected or confirmed active COVID-19 infection
-
Hospital admission for >72 hours prior to randomization
-
Patients receiving non-invasive or invasive ventilation, vasopressors, or extracorporeal life support (ECLS) within an ICU at the time of enrollment
-
Requirement for chronic mechanical ventilation via tracheostomy prior to hospitalization
-
Patients for whom the intent is to not use pharmacologic thromboprophylaxis
-
Patients with an independent indication for therapeutic-dose anticoagulation
-
Patients with a contraindication to therapeutic-dose anticoagulation, including:
- Non-traumatic bleeding that requires medical evaluation or hospitalization within 30 days prior to CAP hospital admission
- History of an inherited or acquired bleeding disorder
- Cerebral aneurysm or mass lesions of the central nervous system
- Ischemic stroke within 3 months of hospital admission
- Gastrointestinal bleeding within 3 months of hospital admission
- Platelet count <50 x109/L OR INR >2.0 OR hemoglobin <80 g/L at the time of screening
- Other physician-perceived contraindications to therapeutic anticoagulation
-
History of heparin induced thrombocytopenia (HIT) or other heparin allergy
-
Current or recent (within 7 days of screening) use of dual anti-platelet inhibitors (For example; Aspirin + one of the following; clopidogrel, ticagrelor, prasugrel)
-
Patients in whom imminent death is anticipated
-
Anticipated transfer to another hospital that is not a study site within 72 hours of randomization
-
Enrollment in other interventional trials related to anticoagulation or antiplatelet therapy during current hospitalization
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Therapeutic-Dose Heparin
Participants randomized to the investigational arm will receive a pragmatic strategy of therapeutic-dose low molecular-weight heparin (LMWH) or unfractionated heparin (UFH) administered daily for up to 14 days or until hospital discharge, whichever occurs first. Participants should start receiving study drug as soon as possible following randomization. |
Preference is for LMWH given ease of administration and possibility of a more favorable safety profile, if no contraindication is present. Enoxaparin, dalteparin, or tinzaparin are acceptable LMWHs to be used for patients in the investigational arm and dose should be based on measured or estimated weight of the patient. Alternatively, intravenous UFH may be used and may be preferred in the presence of significant renal compromise. Intravenous UFH is typically dosed according to total body weight and pragmatically adjusted according to local institutional policy to achieve an activated partial thromboplastin time (aPTT) of 1.5-2.5x the reference value, or a corresponding UFH anti-Xa level. If UFH is used, the availability of a local site policy that specifies an aPTT target in this range or a corresponding anti-Xa value is a requirement. |
|
介入なし:Usual Care
Participants randomized to the control arm will receive usual care thromboprophylactic dose anticoagulation according to local practice. To ensure adequate separation between the study groups, the dose of heparin/LMWH used in the usual care arm should not equal more than half of the approved therapeutic dose for that agent according to local VTE treatment protocols. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Ordinal endpoint reflecting survival
時間枠:30 days
|
Survival to hospital discharge without ICU-level organ support. Organ support is defined as receipt of high flow nasal oxygen, invasive or non-invasive mechanical ventilation, vasopressor/inotropic therapy, or extracorporeal life support (ECLS) within an ICU. This outcome reflects disease progression to ICU-level organ failure or the worst possible outcome (death). It was chosen because of its importance to patients, clinicians, and other stakeholders. Given the limited number of ICU beds, reducing the burden of critical illness has important health system capacity implications. |
30 days
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
すべての原因の死亡率
時間枠:30日、90日、180日
|
30日、90日、180日
|
|
|
Bleeding events
時間枠:14 days
|
Number of participants with major bleeds as defined by the ISTH definition. |
14 days
|
|
HIT events
時間枠:14 days
|
Number of participants with laboratory confirmed heparin induced thrombocytopenia (HIT) |
14 days
|
|
Thrombotic events
時間枠:30 days and 90 days
|
Number of participants with deep vein thrombosis, pulmonary embolism, systemic arterial thromboembolism, myocardial infarction, or ischemic stroke |
30 days and 90 days
|
|
Invasive mechanical ventilation
時間枠:30 days
|
Ordered categorical endpoint with three possible outcomes based on the worst status of each patient through day 30 following randomization |
30 days
|
|
Hospital-free days
時間枠:30 days, 90 days, and 180 days
|
Days alive outside hospital |
30 days, 90 days, and 180 days
|
|
Health related quality of life
時間枠:30 days, 90 days, and 180 days
|
Using the EQ-5D-5L instrument |
30 days, 90 days, and 180 days
|
|
Health related quality of life
時間枠:30 days, 90 days, and 180 days
|
Using the Clinical Frailty Scale instrument |
30 days, 90 days, and 180 days
|
協力者と研究者
スポンサー
協力者
捜査官
- 主任研究者:Patrick Lawler, MD、University Health Network and McGill University
- 主任研究者:Sylvain Lother, MD、University of Manitoba
- 主任研究者:Alexis Turgeon, MD、L'Universite Laval
- 主任研究者:Ryan Zarychanski, MD、University of Manitoba
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。